Topline: While flu, RSV and COVID-19 are relatively low right now, health officials say that could change in the coming weeks ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

"Flu tends to impact us a little later in the year, or early into the new year, so that at this point in time for any of the ...

Researchers estimate that 123,000 to 193,000 U.S. adults were hospitalized each year with respiratory syncytial virus from ...

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...

As family members gather at each other's houses this holiday season, illness might tag along. Here's what you need to know ...

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Enanta Pharmaceuticals (ENTA – Research Report). The associated ...

COLUMBIA - The start of winter is less than a month away, and as temperatures continue to decline cases of the flu and ...